Nowadays, since multi-parametric magnetic resonance imaging (mpMRI) of the prostate has become more accessible worldwide, the evaluation of men with elevated PSA levels and clinical suspicion of prostate cancer, and, thus, the decision to perform a prostate biopsy, has drastically changed. This evidence concerns the gene KLK3 and prostate carcinoma.